Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer.
Hoeltgen L, Meixner E, Hoegen P, Sandrini E, Weykamp F, Forster T, Vinsensia M, Lang K, König L, Arians N, Fremd C, Michel LL, Smetanay K, Schneeweiss A, Wallwiener M, Debus J, Hörner-Rieber J. Hoeltgen L, et al. Among authors: sandrini e. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164537. doi: 10.1177/15330338231164537. Technol Cancer Res Treat. 2023. PMID: 37038619 Free PMC article.
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes.
Regnery S, Katsigiannopulos E, Hoegen P, Weykamp F, Sandrini E, Held T, Deng M, Eichkorn T, Buchele C, Rippke C, Renkamp CK, König L, Lang K, Thomas M, Winter H, Adeberg S, Klüter S, Debus J, Hörner-Rieber J. Regnery S, et al. Among authors: sandrini e. Lung Cancer. 2023 May;179:107175. doi: 10.1016/j.lungcan.2023.03.011. Epub 2023 Mar 21. Lung Cancer. 2023. PMID: 36965207
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Hoegen P, Regnery S, Katsigiannopulos E, Renkamp CK, Lang K, König L, Sandrini E, Meixner E, Rippke C, Buchele C, Liermann J, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: sandrini e. Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786. Cancers (Basel). 2023. PMID: 37345123 Free PMC article.
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
Eichkorn T, Lischalk JW, Hörner-Rieber J, Deng M, Meixner E, Krämer A, Hoegen P, Sandrini E, Regnery S, Held T, Harrabi S, Jungk C, Herfarth K, Debus J, König L. Eichkorn T, et al. Among authors: sandrini e. J Neurooncol. 2023 May;162(3):489-501. doi: 10.1007/s11060-022-04217-y. Epub 2023 Jan 4. J Neurooncol. 2023. PMID: 36598613 Free PMC article.
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S, Leiner L, Buchele C, Hoegen P, Sandrini E, Held T, Deng M, Eichkorn T, Rippke C, Renkamp CK, König L, Lang K, Adeberg S, Debus J, Klüter S, Hörner-Rieber J. Regnery S, et al. Among authors: sandrini e. Radiat Oncol. 2023 May 29;18(1):92. doi: 10.1186/s13014-023-02284-7. Radiat Oncol. 2023. PMID: 37248504 Free PMC article.
Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1-3 following photon and proton radiotherapy.
Eichkorn T, Lischalk JW, Sandrini E, Meixner E, Regnery S, Held T, Bauer J, Bahn E, Harrabi S, Hörner-Rieber J, Herfarth K, Debus J, König L. Eichkorn T, et al. Among authors: sandrini e. Radiother Oncol. 2022 Oct;175:133-143. doi: 10.1016/j.radonc.2022.08.025. Epub 2022 Aug 27. Radiother Oncol. 2022. PMID: 36041565
Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.
Eichkorn T, Bauer J, Bahn E, Lischalk JW, Meixner E, Sandrini E, Regnery S, Held T, Hörner-Rieber J, Alber M, Herfarth K, Debus J, König L, Harrabi S. Eichkorn T, et al. Among authors: sandrini e. Radiother Oncol. 2022 Jul;172:54-64. doi: 10.1016/j.radonc.2022.05.005. Epub 2022 May 11. Radiother Oncol. 2022. PMID: 35568281
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk.
Hoegen P, Katsigiannopulos E, Buchele C, Regnery S, Weykamp F, Sandrini E, Ristau J, Liermann J, Meixner E, Forster T, Renkamp CK, Schlüter F, Rippke C, Debus J, Klüter S, Hörner-Rieber J. Hoegen P, et al. Among authors: sandrini e. Clin Transl Radiat Oncol. 2022 Dec 19;39:100567. doi: 10.1016/j.ctro.2022.100567. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2022. PMID: 36935853 Free PMC article.
Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids.
Meixner E, Hörner-Rieber J, Lischalk JW, Eichkorn T, Krämer A, Sandrini E, Paul A, Hoegen P, Deng M, Welzel T, Erdem S, Debus J, König L. Meixner E, et al. Among authors: sandrini e. Clin Transl Radiat Oncol. 2023 Feb 14;39:100600. doi: 10.1016/j.ctro.2023.100600. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36873269 Free PMC article.
12 results